Kewaunee Scientific Corporation · NASDAQ:KEQU
Kewaunee Scientific — Shareholder Meeting (August 2020)
22 slides from Kewaunee Scientific's shareholder meeting presentation, Aug 26, 2020

Slide 1: Kewaunee Scientific Corporation
Kewaunee Scientific Corporation NASDAQ: KEQU encouraging new discovery…Worldwide Exhibit 99.1

Slide 2: Special Note Regarding Forward-Looking Statements
Special Note Regarding Forward-Looking Statements Certain statements in this document constitute “forward-looking” statements within the meaning of the Private Securities Litigation Reform Act of 1995 (the “Reform Act”). All statements other than statements of historical fact included in this docume

Slide 3: Agenda
Kewaunee Scientific Corporation | NASDAQ: KEQU Agenda Kewaunee Scientific Overview Fiscal Year 2020 Review Outlook and Strategic Direction Q&A

Slide 4: Overview
Kewaunee Scientific Corporation | NASDAQ: KEQU Kewaunee Scientific Overview

Slide 5: Kewaunee Scientific Overview: leading designer and manufacturer of laboratory equipment
Kewaunee Scientific Corporation | NASDAQ: KEQU Kewaunee is a leading global designer, manufacturer, and installer of specialized equipment and technical furniture products for laboratories across an array of industries, including life sciences, education, government, healthcare, and general research

Slide 6: Industries served receive prioritization for investment dollars
Kewaunee Scientific Corporation | NASDAQ: KEQU The industries served by Kewaunee continue to receive prioritization for investment dollars as companies, governments, and institutions look to encourage discovery that is dependent on investment in research and development. Kewaunee Scientific Overview

Slide 7: Active in multiple sectors with end-market diversification
Kewaunee Scientific Corporation | NASDAQ: KEQU Kewaunee is active in multiple sectors, providing geographical and industry diversification. The diversity of end-use segments for the Company’s products supports a narrative of growth and end-market expansion for Kewaunee. Kewaunee Scientific Overview

Slide 8: North American leader in laboratory, healthcare and technical furniture
Kewaunee Scientific Corporation | NASDAQ: KEQU Kewanee is a North American leader in manufactured laboratory, healthcare, and technical furniture. Domestically, the company primarily relies on its dealer and distribution network to sell its products to end users. Kewaunee Scientific Overview Designs

Slide 9: International turn-key laboratory solutions, leading in India and Middle East
Kewaunee Scientific Corporation | NASDAQ: KEQU Internationally, Kewaunee participates throughout the entire laboratory build and operate value chain from pre-construction through post-construction with market leading positions in India and the Middle East Kewaunee Scientific Overview Turn-key provid

Slide 10: FY 2020 Review
Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2020 Review

Slide 11: FY 2020 Review – Consolidated Results
Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2020 Review – Consolidated Results

Slide 12: FY 2020 Review – Enhancements to External Reporting
Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2020 Review – Enhancements to External Reporting Enhancing quarterly reporting by including consolidated EBITDA and segment EBITDA to provide additional insights into the operating performance of the Company’s segments. EBITDA and segment EBITDA are

Slide 13: FY 2020 Review – Domestic Segment
Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2020 Review – Domestic Segment FY 2020 Impacts: Large Middle East order manufactured in the US at negative margins. Restructuring costs incurred during Q2. Significant one-time costs during the FY. Investment in resources focused on muti-year system

Slide 14: FY 2020 Review – International Segment
Kewaunee Scientific Corporation | NASDAQ: KEQU FY 2020 Review – International Segment FY 2020 Impacts: Large strategic Middle East project taken aggressively in prior fiscal year. Withholding tax expense. Closure of China sales office. COVID-19 impacts to cost, productivity and access to constructio

Slide 15: Strategic Direction and Outlook
Kewaunee Scientific Corporation | NASDAQ: KEQU Strategic Direction and Outlook

Slide 16: Strategic Direction and Outlook
Kewaunee Scientific Corporation | NASDAQ: KEQU Strategic Direction and Outlook

Slide 17: To be the global supplier of choice in laboratory furniture and infrastructure
“To be the global supplier of choice with customers in the laboratory furniture and infrastructure markets.” Kewaunee Scientific Corporation | NASDAQ: KEQU Strategic Direction and Outlook

Slide 18: Outlook and Strategic Vision: Our Guiding Principles
Kewaunee Scientific Corporation | NASDAQ: KEQU Outlook and Strategic Vision We will be easy to do business with We will get closer to our customer(s) We will lead and not follow (we are innovators) Our Guiding Principles We will do everything with excellence

Slide 19: Outlook and Strategic Vision
Near term, COVID-19 will continue to impact the rate of activity in the marketplace and the pace of construction activity. Long term, COVID-19 will result in investments in infrastructure that require Kewaunee’s products. Continue investing in domestic technology infrastructure. Re-capitalization of

Slide 20: Thank You and Questions
Kewaunee Scientific Corporation | NASDAQ: KEQU Thank You and Questions

Slide 21: Appendix
Kewaunee Scientific Corporation | NASDAQ: KEQU Appendix

Slide 22: Non-GAAP Reconciliations
Kewaunee Scientific Corporation | NASDAQ: KEQU Non-GAAP Reconciliations Kewaunee Scientific Corporation Kewaunee Scientific Corporation Annual Shareholder Meeting | August 26, 2020 Appendix: Non-GAAP Measures (Dollars in Thousands) The following unaudited tables reconcile Net Earnings to EBITDA, by
Source: SEC EDGAR · 8-K filed Aug 26, 2020
More decks from Kewaunee Scientific Corporation
Q1 FY2027 Earnings Presentation20 slides · September 2026
Shareholder Meeting (August 2026)17 slides · Aug 26, 2026
FY2026 Earnings Presentation21 slides · June 2026
Q3 FY2026 Earnings Presentation22 slides · March 2026
Q2 FY2026 Earnings Presentation22 slides · December 2025
Q1 FY2026 Earnings Presentation22 slides · September 2025